6 case(s) found.
Case A presents three strategic options considered by a fictitious international oil and gas corporation to address the issue of climate change: "fight against action", "wait and see", and "dynamic proactive".
Case B presents the climate change strategies of three multinational corporations – ExxonMobil, BP Amoco, and TotalFinaElf.
Reference 4957
Published 03 Jan 2004
Length 19 page(s)
Topic Strategy
Region Global
Industry Oil & Energy
Case A presents three strategic options considered by a fictitious international oil and gas corporation to address the issue of climate change: "fight against action", "wait and see", and "dynamic proactive".
Case B presents the climate change strategies of three multinational corporations – ExxonMobil, BP Amoco, and TotalFinaElf.
Case A presents three strategic options considered by a fictitious international oil and gas corporation to address the issue of climate change: "fight against action", "wait and see", and "dynamic proactive".
Case B presents the climate change strategies of three multinational corporations – ExxonMobil, BP Amoco, and TotalFinaElf.
Case A presents three strategic options considered by a fictitious international oil and gas corporation to address the issue of climate change: "fight against action", "wait and see", and "dynamic proactive".
Case B presents the climate change strategies of three multinational corporations – ExxonMobil, BP Amoco, and TotalFinaElf.
The case covers all major aspects of Benetton's successful corporate strategy and innovative business system from its creation till the present. It also provides a complete overview of Benetton's unique communication philosophy and the controversy generated by it, along with a wealth of independent market research data from many countries.
Pedagogical Objectives
The case covers all major aspects of Benetton's successful corporate strategy and innovative business system from its creation till the present. It also provides a complete overview of Benetton's unique communication philosophy and the controversy generated by it, along with a wealth of independent market research data from many countries.
Pedagogical Objectives
This is the first of a three-case series. In October 1988, members of the Board and CEO's (chief executive officers) of Roussel-Uclaf (one of the French leaders of the pharmaceutical industry) had to decide whether or not to put in the market RU 486, a pill that provokes abortion without use of surgical methods.
Reference 2886
Published 05 Jan 2005
Length 15 page(s)
Region Europe
This is the first of a three-case series. In October 1988, members of the Board and CEO's (chief executive officers) of Roussel-Uclaf (one of the French leaders of the pharmaceutical industry) had to decide whether or not to put in the market RU 486, a pill that provokes abortion without use of surgical methods.
This is a French translation of the case?. This is the first of a three-case series. In October 1988, members of the Board and CEO's (chief executive officers) of Roussel-Uclaf (one of the French leaders of the pharmaceutical industry) had to decide whether or not to put in the market RU 486, a pill that provokes abortion without use of surgical methods.
Reference 2886
Published 05 Jan 2005
Length 5 page(s)
Region Europe
This is a French translation of the case?. This is the first of a three-case series. In October 1988, members of the Board and CEO's (chief executive officers) of Roussel-Uclaf (one of the French leaders of the pharmaceutical industry) had to decide whether or not to put in the market RU 486, a pill that provokes abortion without use of surgical methods.
This is a French translation of the case?. This is the first of a three-case series. In October 1988, members of the Board and CEO's (chief executive officers) of Roussel-Uclaf (one of the French leaders of the pharmaceutical industry) had to decide whether or not to put in the market RU 486, a pill that provokes abortion without use of surgical methods.
Reference 2886
Published 01 Jul 2005
Length 14 page(s)
Region Europe
This is a French translation of the case?. This is the first of a three-case series. In October 1988, members of the Board and CEO's (chief executive officers) of Roussel-Uclaf (one of the French leaders of the pharmaceutical industry) had to decide whether or not to put in the market RU 486, a pill that provokes abortion without use of surgical methods.